• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD22和蛋白酪氨酸磷酸酶SHP在B细胞激活中的作用。

A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP.

作者信息

Doody G M, Justement L B, Delibrias C C, Matthews R J, Lin J, Thomas M L, Fearon D T

机构信息

Wellcome Trust Immunology Unit, Department of Medicine, University of Cambridge, School of Clinical Medicine, UK.

出版信息

Science. 1995 Jul 14;269(5221):242-4. doi: 10.1126/science.7618087.

DOI:10.1126/science.7618087
PMID:7618087
Abstract

CD22 is a membrane immunoglobulin (mIg)-associated protein of B cells. CD22 is tyrosine-phosphorylated when mIg is ligated. Tyrosine-phosphorylated CD22 binds and activates SHP, a protein tyrosine phosphatase known to negatively regulate signaling through mIg. Ligation of CD22 to prevent its coaggregation with mIg lowers the threshold at which mIg activates the B cell by a factor of 100. In secondary lymphoid organs, CD22 may be sequestered away from mIg through interactions with counterreceptors on T cells. Thus, CD22 is a molecular switch for SHP that may bias mIg signaling to anatomic sites rich in T cells.

摘要

CD22是B细胞的一种膜免疫球蛋白(mIg)相关蛋白。当mIg被连接时,CD22会发生酪氨酸磷酸化。酪氨酸磷酸化的CD22结合并激活SHP,SHP是一种已知可通过mIg负向调节信号传导的蛋白酪氨酸磷酸酶。连接CD22以防止其与mIg共聚集,可将mIg激活B细胞的阈值降低100倍。在二级淋巴器官中,CD22可能通过与T细胞上的反受体相互作用而与mIg隔离。因此,CD22是SHP的分子开关,可能会使mIg信号偏向富含T细胞的解剖部位。

相似文献

1
A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP.CD22和蛋白酪氨酸磷酸酶SHP在B细胞激活中的作用。
Science. 1995 Jul 14;269(5221):242-4. doi: 10.1126/science.7618087.
2
CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.在B细胞活化时,CD22与蛋白酪氨酸磷酸酶1C、脾酪氨酸激酶和磷脂酶C-γ1相互作用。
J Exp Med. 1996 Feb 1;183(2):547-60. doi: 10.1084/jem.183.2.547.
3
CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1.CD45调节CD22的酪氨酸磷酸化及其与蛋白酪氨酸磷酸酶SHP-1的关联。
J Immunol. 1999 May 1;162(9):5278-86.
4
Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C.CD22与蛋白酪氨酸磷酸酶1C之间的磷酸酪氨酸依赖性结合。
Eur J Immunol. 1995 Jun;25(6):1573-9. doi: 10.1002/eji.1830250616.
5
Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22.蛋白质酪氨酸磷酸酶SHP-1与CD22之间相互作用位点的定义。
J Biol Chem. 1999 Jan 22;274(4):2303-7. doi: 10.1074/jbc.274.4.2303.
6
CD22 is a functional ligand for SH2 domain-containing protein-tyrosine phosphatase-1 in primary T cells.CD22是原代T细胞中含SH2结构域的蛋白酪氨酸磷酸酶-1的功能性配体。
J Biol Chem. 2004 Nov 12;279(46):47783-91. doi: 10.1074/jbc.M402354200. Epub 2004 Sep 10.
7
Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation.黏附受体CD22的激活会触发B细胞的强大刺激信号,而阻断CD22/CD22L相互作用会损害T细胞增殖。
Blood. 1996 Jun 1;87(11):4723-30.
8
Inhibition of the B cell by CD22: a requirement for Lyn.CD22对B细胞的抑制作用:Lyn的必要性。
J Exp Med. 1998 Mar 2;187(5):807-11. doi: 10.1084/jem.187.5.807.
9
Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.多基因自身免疫性状:Lyn、CD22和SHP-1是调节BCR信号传导和选择的生化途径的限制因素。
Immunity. 1998 Apr;8(4):497-508. doi: 10.1016/s1074-7613(00)80554-3.
10
Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway.Lyn/CD22/SHP1 途径对 B 细胞抗原受体信号传导的调控
Curr Top Microbiol Immunol. 1999;244:57-68. doi: 10.1007/978-3-642-58537-1_5.

引用本文的文献

1
M2-Like Macrophages Exhibit Sialic Acid-Enhanced Efferocytosis via the Siglec CD22.M2样巨噬细胞通过唾液酸结合免疫球蛋白样凝集素CD22表现出唾液酸增强的噬菌作用。
FASEB J. 2025 Jul 15;39(13):e70767. doi: 10.1096/fj.202500146RR.
2
Research Advances in the Immunomodulatory Functions of CD100/SEMA4D and Their Roles in Viral Infectious Diseases.CD100/SEMA4D的免疫调节功能及其在病毒感染性疾病中的作用的研究进展
Int J Mol Sci. 2025 May 2;26(9):4341. doi: 10.3390/ijms26094341.
3
Cord blood platelet-rich plasma: proteomics analysis for ophthalmic applications.
脐血富血小板血浆:眼科应用的蛋白质组学分析
Clin Proteomics. 2025 Jan 3;22(1):1. doi: 10.1186/s12014-024-09524-2.
4
Antibody-drug conjugates in cancer therapy: mechanisms and clinical studies.癌症治疗中的抗体药物偶联物:作用机制与临床研究
MedComm (2020). 2024 Jul 28;5(8):e671. doi: 10.1002/mco2.671. eCollection 2024 Aug.
5
Siglec-15/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis.Siglec-15/唾液酸轴作为乳腺癌骨转移中的中央糖免疫检查点。
Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2312929121. doi: 10.1073/pnas.2312929121. Epub 2024 Jan 22.
6
CD22L Conjugation to Insulin Attenuates Insulin-Specific B Cell Activation.CD22 与胰岛素缀合可减弱胰岛素特异性 B 细胞的活化。
Bioconjug Chem. 2023 Nov 15;34(11):2077-2088. doi: 10.1021/acs.bioconjchem.3c00391. Epub 2023 Oct 26.
7
Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.Siglecs 作为人类肥大细胞和/或嗜酸性粒细胞相关疾病治疗的潜在靶点。
Semin Immunol. 2023 Sep;69:101799. doi: 10.1016/j.smim.2023.101799. Epub 2023 Jul 4.
8
Combination of High-Resolution Structures for the B Cell Receptor and Co-Receptors Provides an Understanding of Their Interactions with Therapeutic Antibodies.B细胞受体和共受体的高分辨率结构组合有助于理解它们与治疗性抗体的相互作用。
Cancers (Basel). 2023 May 23;15(11):2881. doi: 10.3390/cancers15112881.
9
Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers.靶抗原特性及其对血液系统恶性肿瘤和实体瘤中临床批准的抗体药物偶联物(ADC)的贡献
Cancers (Basel). 2023 Mar 19;15(6):1845. doi: 10.3390/cancers15061845.
10
Emerging phagocytosis checkpoints in cancer immunotherapy.癌症免疫治疗中的新兴吞噬检查点。
Signal Transduct Target Ther. 2023 Mar 7;8(1):104. doi: 10.1038/s41392-023-01365-z.